(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Acorn Energy, Atossa Therapeutics, and Smith & Wesson.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Acorn Energy (ACFN) | 0.44 | 22.28% | 2023-09-07 23:48:07 |
| 2 | Atossa Therapeutics (ATOS) | 0.85 | 14.36% | 2023-09-08 11:15:07 |
| 3 | Smith & Wesson (SWBI) | 11.85 | 12.75% | 2023-09-08 12:20:15 |
| 4 | Canopy Growth (CGC) | 0.84 | 10.91% | 2023-09-08 12:39:44 |
| 5 | Aurora Cannabis (ACB) | 0.50 | 9.31% | 2023-09-08 13:02:46 |
| 6 | Viking Therapeutics (VKTX) | 15.81 | 8.21% | 2023-09-08 12:33:42 |
| 7 | FibroGen (FGEN) | 1.06 | 6.77% | 2023-09-08 12:27:26 |
| 8 | GlaxoSmithKline (GSK) | 36.56 | 5.53% | 2023-09-08 12:56:07 |
| 9 | Groupon (GRPN) | 12.04 | 4.7% | 2023-09-08 12:28:01 |
| 10 | DISH Network (DISH) | 6.28 | 4.49% | 2023-09-08 12:26:52 |
The three biggest losers today are Restoration Hardware Holdings, Marathon, and Nikola.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Restoration Hardware Holdings (RH) | 314.84 | -14.57% | 2023-09-08 12:59:23 |
| 2 | Marathon (MARA) | 10.59 | -14.32% | 2023-09-08 12:28:55 |
| 3 | Nikola (NKLA) | 0.89 | -14.14% | 2023-09-08 12:19:40 |
| 4 | AMC (AMC) | 7.22 | -11.04% | 2023-09-08 12:34:19 |
| 5 | AcelRx Pharmaceuticals (ACRX) | 0.89 | -8.43% | 2023-09-08 01:09:06 |
| 6 | AMC Networks (AMCX) | 10.09 | -8.11% | 2023-09-08 05:23:07 |
| 7 | Advanced Energy Industries (AEIS) | 105.74 | -7.52% | 2023-09-08 03:08:07 |
| 8 | Alpha and Omega Semiconductor Limited (AOSL) | 29.21 | -6.94% | 2023-09-08 07:48:08 |
| 9 | Axogen (AXGN) | 5.52 | -6.6% | 2023-09-08 13:14:06 |
| 10 | Bilibili (BILI) | 13.41 | -6.24% | 2023-09-08 12:51:31 |
Winners today
1. Acorn Energy (ACFN) – 22.28%
Acorn Energy, Inc., through its subsidiaries, develops and markets wireless remote monitoring and control systems for various markets in the United States and internationally. It operates through two segments, Power Generation (PG) Monitoring and Cathodic Protection (CP) Monitoring. The PG segment provides wireless remote monitoring and control systems, and services for critical assets, which include stand-by power generators, compressors, pumps, pumpjacks, light towers, turbines, and other industrial equipment; and Internet of Things applications. The CP segment offers remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies. The company was incorporated in 1986 and is based in Wilmington, Delaware.
NASDAQ ended the session with Acorn Energy rising 22.28% to $0.44 on Friday, following the last session’s upward trend. NASDAQ rose 0.09% to $13,761.53, after four consecutive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Acorn Energy has a trailing twelve months EPS of $-0.01.
Moving Average
Acorn Energy’s value is way higher than its 50-day moving average of $0.33 and way higher than its 200-day moving average of $0.33.
More news about Acorn Energy.
2. Atossa Therapeutics (ATOS) – 14.36%
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Atossa Therapeutics jumping 14.36% to $0.85 on Friday while NASDAQ rose 0.09% to $13,761.53.
Earnings Per Share
As for profitability, Atossa Therapeutics has a trailing twelve months EPS of $-0.23.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.89%.
More news about Atossa Therapeutics.
3. Smith & Wesson (SWBI) – 12.75%
Smith & Wesson Brands, Inc. designs, manufactures, and sells firearms worldwide. The company offers handguns, including revolvers and pistols; long guns, such as modern sporting rifles, bolt action rifles; handcuffs; suppressors; and other firearm-related products under the Smith & Wesson, M&P, and Gemtech brands. It also provides manufacturing services comprising forging, heat treating, rapid prototyping, tooling, finishing, plating, machining, and custom plastic injection molding to other businesses under the Smith & Wesson and Smith & Wesson Precision Components brand names; and sells parts purchased through third parties. The company sells its products to firearm enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement, security agencies and officers, and military agencies. It markets its products through independent dealers, retailers, in-store retails, and direct to consumers; print, broadcast, and digital advertising campaigns; social and electronic media; and in-store retail merchandising strategies. Smith & Wesson Brands, Inc. was founded in 1852 and is based in Springfield, Massachusetts.
NASDAQ ended the session with Smith & Wesson jumping 12.75% to $11.85 on Friday while NASDAQ jumped 0.09% to $13,761.53.
Earnings Per Share
As for profitability, Smith & Wesson has a trailing twelve months EPS of $0.8.
PE Ratio
Smith & Wesson has a trailing twelve months price to earnings ratio of 14.81. Meaning, the purchaser of the share is investing $14.81 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.9%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 28.6% and a negative 9.5%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Smith & Wesson’s EBITDA is 20.8.
More news about Smith & Wesson.
4. Canopy Growth (CGC) – 10.91%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth jumping 10.91% to $0.84 on Friday, after two consecutive sessions in a row of losses. NASDAQ jumped 0.09% to $13,761.53, after four sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.
: canopy growth stock soars on heavy volume again, amid cannabis investor optimism over possible favorable legislationShares of Canopy Growth Corp. shot up 21.7% toward a near four-month high in very active afternoon trading, putting them on track for the fifth double-digit percentage gain in seven sessions.
Canopy growth stock soars amid cannabis investor optimism for legislationShares of Canopy Growth Corp. shot up 21.7% toward a near four-month high in very active afternoon trading, putting them on track for the fifth double-digit percentage gain in seven sessions.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-1.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.56%.
Volume
Today’s last reported volume for Canopy Growth is 66663200 which is 85.5% above its average volume of 35935700.
Moving Average
Canopy Growth’s value is way above its 50-day moving average of $0.49 and way below its 200-day moving average of $1.82.
Sales Growth
Canopy Growth’s sales growth for the current quarter is negative 9.4%.
More news about Canopy Growth.
5. Aurora Cannabis (ACB) – 9.31%
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.
NYSE ended the session with Aurora Cannabis jumping 9.31% to $0.50 on Friday, after four consecutive sessions in a row of losses. NYSE rose 0.09% to $15,878.99, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-5.66.
More news about Aurora Cannabis.
6. Viking Therapeutics (VKTX) – 8.21%
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
NASDAQ ended the session with Viking Therapeutics jumping 8.21% to $15.81 on Friday, following the last session’s downward trend. NASDAQ jumped 0.09% to $13,761.53, after four sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Viking Therapeutics has a trailing twelve months EPS of $-0.94.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.88%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 4.8% and positive 7.7% for the next.
Moving Average
Viking Therapeutics’s worth is above its 50-day moving average of $15.62 and way higher than its 200-day moving average of $13.49.
Volatility
Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 0.43%, 0.14%, and 3.07%.
Viking Therapeutics’s highest amplitude of average volatility was 2.90% (last week), 2.07% (last month), and 3.07% (last quarter).
More news about Viking Therapeutics.
7. FibroGen (FGEN) – 6.77%
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
NASDAQ ended the session with FibroGen rising 6.77% to $1.06 on Friday while NASDAQ jumped 0.09% to $13,761.53.
Earnings Per Share
As for profitability, FibroGen has a trailing twelve months EPS of $-3.49.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1015.79%.
Yearly Top and Bottom Value
FibroGen’s stock is valued at $1.06 at 17:32 EST, way under its 52-week high of $25.69 and way higher than its 52-week low of $0.91.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 36.7% and 45.7%, respectively.
Volatility
FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 10.07%, a negative 2.49%, and a positive 4.57%.
FibroGen’s highest amplitude of average volatility was 10.07% (last week), 5.88% (last month), and 4.57% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FibroGen’s stock is considered to be overbought (>=80).
More news about FibroGen.
8. GlaxoSmithKline (GSK) – 5.53%
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
NYSE ended the session with GlaxoSmithKline rising 5.53% to $36.56 on Friday while NYSE jumped 0.09% to $15,878.99.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $3.2.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 11.42. Meaning, the purchaser of the share is investing $11.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.22%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GlaxoSmithKline’s stock is considered to be overbought (>=80).
More news about GlaxoSmithKline.
9. Groupon (GRPN) – 4.7%
Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Groupon rising 4.7% to $12.04 on Friday, following the last session’s upward trend. NASDAQ rose 0.09% to $13,761.53, after four successive sessions in a row of losses, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Groupon has a trailing twelve months EPS of $-4.7.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -309.27%.
More news about Groupon.
10. DISH Network (DISH) – 4.49%
DISH Network Corporation, together with its subsidiaries, provides pay-TV services in the United States. The company operates in two segments, Pay-TV and Wireless. It offers video services under the DISH TV brand; and programming packages that include programming through national broadcast networks, local broadcast networks, and national and regional cable networks, as well as regional and specialty sports channels, premium movie channels, and Latino and international programming packages. The company also provides access to movies and television shows through TV or Internet-connected devices; and dishanywhere.com and mobile applications on Internet-connected devices to view authorized content, search program listings, and remotely control certain features of their DVRs. In addition, it offers Sling TV services, including Sling domestic, Sling International, Sling Latino, Sling Orange, and Sling Blue services that require an internet connection and are available on streaming-capable devices, such as streaming media devices, TVs, tablets, computers, game consoles, and phones, as well as market SLING TV services to consumers who do not subscribe to traditional satellite and cable pay-TV services. Further, the company provides wireless subscribers consumer plans with no annual service contracts, as well as monthly service plans, including high-speed data and unlimited talk and text. The company offers receiver systems and programming through direct sales channels, as well as independent third parties, such as small retailers, direct marketing groups, local and regional consumer electronics stores, retailers, and telecommunications companies. DISH Network Corporation was founded in 1980 and is headquartered in Englewood, Colorado.
NASDAQ ended the session with DISH Network jumping 4.49% to $6.28 on Friday while NASDAQ rose 0.09% to $13,761.53.
Earnings Per Share
As for profitability, DISH Network has a trailing twelve months EPS of $2.68.
PE Ratio
DISH Network has a trailing twelve months price to earnings ratio of 2.34. Meaning, the purchaser of the share is investing $2.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.31%.
Moving Average
DISH Network’s value is way below its 50-day moving average of $7.00 and way under its 200-day moving average of $10.05.
Yearly Top and Bottom Value
DISH Network’s stock is valued at $6.28 at 17:32 EST, way under its 52-week high of $19.89 and higher than its 52-week low of $5.83.
More news about DISH Network.
Losers Today
1. Restoration Hardware Holdings (RH) – -14.57%
RH, together with its subsidiaries, operates as a retailer in the home furnishings and operates under RH Galleries and RH brand names in the District of Columbia and Canada, as well as Waterworks showrooms throughout the United States and the United Kingdom. It offers products in various categories, including furniture, lighting, textiles, bathware, décor, outdoor and garden, and child and teen furnishings. The company provides its products through its retail galleries; online through rh.com, rhbabyandchild.com, rhteen.com, and rhmodern.com, as well as waterworks.com, and Source Books, a series of catalogs. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was incorporated in 2011 and is headquartered in Corte Madera, California.
NYSE ended the session with Restoration Hardware Holdings dropping 14.57% to $314.84 on Friday, after two successive sessions in a row of losses. NYSE jumped 0.09% to $15,878.99, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Restoration Hardware Holdings has a trailing twelve months EPS of $13.96.
PE Ratio
Restoration Hardware Holdings has a trailing twelve months price to earnings ratio of 22.55. Meaning, the purchaser of the share is investing $22.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.91%.
Yearly Top and Bottom Value
Restoration Hardware Holdings’s stock is valued at $314.84 at 17:32 EST, way below its 52-week high of $406.38 and way above its 52-week low of $227.00.
More news about Restoration Hardware Holdings.
2. Marathon (MARA) – -14.32%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.
NASDAQ ended the session with Marathon falling 14.32% to $10.59 on Friday while NASDAQ jumped 0.09% to $13,761.53.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-4.07.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.14%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Marathon’s stock is valued at $10.59 at 17:32 EST, way under its 52-week high of $19.88 and way higher than its 52-week low of $3.11.
More news about Marathon.
3. Nikola (NKLA) – -14.14%
Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.
NASDAQ ended the session with Nikola sliding 14.14% to $0.89 on Friday while NASDAQ jumped 0.09% to $13,761.53.
Earnings Per Share
As for profitability, Nikola has a trailing twelve months EPS of $-1.29.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -132.55%.
Moving Average
Nikola’s value is way below its 50-day moving average of $1.86 and way below its 200-day moving average of $1.82.
More news about Nikola.
4. AMC (AMC) – -11.04%
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.
NYSE ended the session with AMC sliding 11.04% to $7.22 on Friday, after two consecutive sessions in a row of losses. NYSE rose 0.09% to $15,878.99, after three successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, AMC has a trailing twelve months EPS of $-5.4.
Previous days news about AMC
- : AMC stock tumbles after filing prospectus supplement for the sale of up to 40 million shares. According to MarketWatch on Wednesday, 6 September, "Shares of AMC Entertainment Holdings Inc. tumbled Thursday after the movie-theater operator disclosed an equity-distribution agreement in which the company could sell up to 40 million common shares."
- AMC shares tumble toward lowest levels since January 2021. According to MarketWatch on Wednesday, 6 September, "Shares of AMC Entertainment Holdings Inc. tumbled Thursday after the movie-theater operator disclosed an equity-distribution agreement in which the company could sell up to 40 million common shares."
- AMC shares stumble after filing of stock-issuance prospectus. According to MarketWatch on Wednesday, 6 September, "Shares of AMC Entertainment Holdings Inc. tumbled Thursday after the movie-theater operator disclosed an equity-distribution agreement in which the company could sell up to 40 million common shares."
More news about AMC.
5. AcelRx Pharmaceuticals (ACRX) – -8.43%
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California.
NASDAQ ended the session with AcelRx Pharmaceuticals dropping 8.43% to $0.89 on Friday while NASDAQ jumped 0.09% to $13,761.53.
Earnings Per Share
As for profitability, AcelRx Pharmaceuticals has a trailing twelve months EPS of $-3.33.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.64%.
Yearly Top and Bottom Value
AcelRx Pharmaceuticals’s stock is valued at $0.89 at 17:32 EST, way below its 52-week high of $5.80 and way higher than its 52-week low of $0.55.
Moving Average
AcelRx Pharmaceuticals’s value is way below its 50-day moving average of $1.03 and way below its 200-day moving average of $1.32.
Revenue Growth
Year-on-year quarterly revenue growth declined by 55.6%, now sitting on 2.02M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AcelRx Pharmaceuticals’s EBITDA is 2.08.
More news about AcelRx Pharmaceuticals.
6. AMC Networks (AMCX) – -8.11%
AMC Networks Inc., an entertainment company, owns and operates a suite of video entertainment products that are delivered to audiences and a platform to distributors and advertisers in the United States and internationally. The company operates in two segments, National Networks; and International and Other. The National Networks segment operates five national programming networks under the AMC, WE tv, BBC AMERICA, IFC, and SundanceTV names. This segment also produces original programming for its programming networks; and licenses, such as programming worldwide, as well as services the national programming networks. The International and Other segment operates a portfolio of channels under the AMCNI name worldwide; subscription streaming business under the Acorn TV, Shudder, Sundance Now, ALLBLK, and AMC+ names; production and comedy venues activities under the Levity name; and film distribution business under the IFC Films name. The company was founded in 1980 and is headquartered in New York, New York.
NASDAQ ended the session with AMC Networks dropping 8.11% to $10.09 on Friday while NASDAQ rose 0.09% to $13,761.53.
Earnings Per Share
As for profitability, AMC Networks has a trailing twelve months EPS of $-0.18.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.25%.
Sales Growth
AMC Networks’s sales growth is negative 16.3% for the ongoing quarter and negative 23.3% for the next.
Moving Average
AMC Networks’s value is way under its 50-day moving average of $12.35 and way under its 200-day moving average of $15.79.
More news about AMC Networks.
7. Advanced Energy Industries (AEIS) – -7.52%
Advanced Energy Industries, Inc. designs, manufactures, sells, and supports precision power conversion, measurement, and control solutions worldwide. It offers plasma power solutions, including direct current (DC), pulsed DC, low frequency alternating current, high voltage, and radio frequency (RF) power supplies, as well as RF power supplies, RF matching networks, and RF instrumentation products; and remote plasma sources for reactive gas applications. The company also provides power control modules and thermal instrumentation products for rapid thermal processing, chemical vapor deposition, epitaxy, crystal growing, and chemical processing, as well as metal, carbon fiber, and glass manufacturing and other industrial power applications; high voltage DC-DC products for semiconductor wafer processing and metrology, electrostatic clamping of substrates, scientific instrumentation, mass spectrometry, and X-ray systems for industrial and analytical applications; and low voltage DC-DC board mounted solutions for use in healthcare, telecommunications, test and measurement, instrumentation, and industrial equipment applications, as well as distributed power in server and storage systems. In addition, it offers gas sensing and monitoring products for the energy market, air quality monitoring, and automobile emission monitoring and testing; and embedded power products for medical equipment or IEC 60950-1 for information technology equipment. Further, it offers conversions, upgrades, and refurbishments and used equipment to companies, as well as repair services. The company provides its products through a direct sales force, independent sales representatives, channel partners, and distributors. Advanced Energy Industries, Inc. was incorporated in 1981 and is headquartered in Denver, Colorado.
NASDAQ ended the session with Advanced Energy Industries sliding 7.52% to $105.74 on Friday, following the last session’s downward trend. NASDAQ rose 0.09% to $13,761.53, after four sequential sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Implied volatility surging for advanced energy industries (aeis) stock optionsCurrently, Advanced Energy Industries is a Zacks Rank #3 (Hold) in the Semiconductor Equipment – Wafer Fabrication industry that ranks in the Top 12% of our Zacks Industry Rank. , Clearly, options traders are pricing in a big move for Advanced Energy Industries shares, but what is the fundamental picture for the company?
Earnings Per Share
As for profitability, Advanced Energy Industries has a trailing twelve months EPS of $4.76.
PE Ratio
Advanced Energy Industries has a trailing twelve months price to earnings ratio of 22.21. Meaning, the purchaser of the share is investing $22.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.5%.
More news about Advanced Energy Industries.
8. Alpha and Omega Semiconductor Limited (AOSL) – -6.94%
Alpha and Omega Semiconductor Limited designs, develops, and supplies power semiconductor products for computing, consumer electronics, communication, and industrial applications in Hong Kong, China, South Korea, the United States, and internationally. It offers power discrete products, including metal-oxide-semiconductor field-effect transistors (MOSFET), SRFETs, XSFET, electrostatic discharge, protected MOSFETs, high and mid-voltage MOSFETs, and insulated gate bipolar transistors for use in smart phone chargers, battery packs, notebooks, desktop and servers, data centers, base stations, graphics card, game boxes, TVs, AC adapters, power supplies, motor control, power tools, e-vehicles, white goods and industrial motor drives, UPS systems, solar inverters, and industrial welding. The company also provides power ICs that deliver power, as well as control and regulate the power management variables, such as the flow of current and level of voltage. Its power ICs are used in flat panel displays, TVs, notebooks, graphic cards, servers, DVD/Blu-Ray players, set-top boxes, and networking equipment. In addition, the company offers aMOS5 MOSFET for quick charger, adapter, PC power, server, industrial power, telecom, and datacenter applications. Further, it provides coil drivers for cordless power tools, vacuum cleaners, drones, and other electronic equipment; transient voltage suppressors; EZBuck regulators; HVICs; silicon carbide product for industrial applications, such as solar inverters, UPS, and battery management systems; and type-C power delivery protection switches. Alpha and Omega Semiconductor Limited was incorporated in 2000 and is headquartered in Sunnyvale, California.
NASDAQ ended the session with Alpha and Omega Semiconductor Limited sliding 6.94% to $29.21 on Friday, after three sequential sessions in a row of losses. NASDAQ rose 0.09% to $13,761.53, after four sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Alpha and Omega Semiconductor Limited has a trailing twelve months EPS of $0.39.
PE Ratio
Alpha and Omega Semiconductor Limited has a trailing twelve months price to earnings ratio of 74.9. Meaning, the purchaser of the share is investing $74.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.42%.
Yearly Top and Bottom Value
Alpha and Omega Semiconductor Limited’s stock is valued at $29.21 at 17:32 EST, way below its 52-week high of $38.87 and way higher than its 52-week low of $20.64.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Alpha and Omega Semiconductor Limited’s EBITDA is 1.
Moving Average
Alpha and Omega Semiconductor Limited’s value is below its 50-day moving average of $31.77 and under its 200-day moving average of $29.44.
Revenue Growth
Year-on-year quarterly revenue growth declined by 16.7%, now sitting on 691.32M for the twelve trailing months.
More news about Alpha and Omega Semiconductor Limited.
9. Axogen (AXGN) – -6.6%
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
NASDAQ ended the session with Axogen falling 6.6% to $5.52 on Friday while NASDAQ rose 0.09% to $13,761.53.
Earnings Per Share
As for profitability, Axogen has a trailing twelve months EPS of $-0.53.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.6%.
Sales Growth
Axogen’s sales growth is 12.1% for the ongoing quarter and 11.3% for the next.
Yearly Top and Bottom Value
Axogen’s stock is valued at $5.52 at 17:32 EST, way under its 52-week high of $13.66 and above its 52-week low of $5.38.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.7%, now sitting on 147.94M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Axogen’s EBITDA is 1.94.
More news about Axogen.
10. Bilibili (BILI) – -6.24%
Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. Its platform offers a range of content, including video services, mobile games, and value-added service, as well as ACG-related comic and audio content. The company's video services include professional user generated videos, occupationally generated videos, live broadcasting, and story mode. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.
NASDAQ ended the session with Bilibili dropping 6.24% to $13.41 on Friday, following the last session’s downward trend. NASDAQ rose 0.09% to $13,761.53, after four sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Bilibili has a trailing twelve months EPS of $-1.73.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.27%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 60.6% and 54.2%, respectively.
Volume
Today’s last reported volume for Bilibili is 6947860 which is 8.23% above its average volume of 6418960.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Bilibili’s EBITDA is 0.24.
Sales Growth
Bilibili’s sales growth is negative 5.8% for the present quarter and 3.5% for the next.
More news about Bilibili.
Stay up to date with our winners and losers daily report
